만성완전폐색(CTO) 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)

Global Chronic Total Occlusion Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

US $ 3,920 ￦ 5,816,000

PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 4,730 ￦ 7,017,000

PDF & Excel (10-user License)

PDF 및 Excel 보고서를 동일 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

US $ 7,430 ￦ 11,023,000

PDF & Excel (Corporate User License)

PDF 및 Excel 보고서를 동일 기업 내 모든 사용자가 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 전자파일의 이용 범위와 동일합니다.

한글목차

세계의 만성완전폐색(CTO) 시장은 2025-2033년 주목할 만한 CAGR 6.49%로 성장할 것으로 예측됩니다. 2033년까지 시장 규모는 43억 9,000만 달러로 급증하여 2024년 기록한 24억 9,000만 달러에서 대폭 증가할 것으로 예측됩니다.

만성완전폐색(CTO) 시장은 복잡한 관상동맥 폐색의 치료를 목적으로 하는 인터벤셔널 카디올로지 기술과 장치의 진보에 의해 성장이 예상되고 있습니다. 가이드와이어, 마이크로카테터 및 재진입 장치의 혁신은 절차의 성공률과 환자 결과를 개선하고 있습니다. 향후 개발은 혈관내 초음파(IVUS) 및 광간섭 단층계(OCT)와 같은 이미징 기술에 초점을 맞추어 병변의 시각화 및 인터벤션 가이드를 강화할 것입니다.

또한 심혈관 질환의 유병률 증가와 고령화로 환자층이 확대되고 있습니다. CTO 절차에서 AI 및 로봇 공학의 통합은 정확성을 높이고 합병증을 감소시킵니다. 임상 연구 및 지침 업데이트는 CTO 인터벤션의 광범위한 채용을 지원합니다. 심혈관 치료가 진행됨에 따라 CTO 시장은 혁신을 계속할 것이며 효과적이고 침습적인 치료 옵션을 제공할 것입니다.

목차

제1장 서문

제2장 주요 요약

• 시장의 하이라이트
• 세계 시장 현황

제3장 만성완전폐색(CTO) : 산업 분석

• 서문 : 시장 역학
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 업계 동향
• Porter's Five Forces 분석
• 시장 매력 분석

제4장 밸류체인 분석

• 밸류체인 분석
• 원재료 분석
  • 원재료 리스트
  • 원재료 제조업체 리스트
  • 주요 원재료의 가격 동향
• 잠재적 구매자 목록
• 마케팅 채널
  • 직접 마케팅
  • 간접 마케팅
  • 마케팅 채널 발전 동향

제5장 세계의 만성완전폐색(CTO) 시장 분석 : 제품 유형별

• 개요 : 제품 유형별
• 과거 및 예측 데이터 분석 : 제품 유형별
• 마이크로카테터
• 가이드와이어
• 풍선 카테터
• 크로스 디바이스
• 스텐트
• 기타

제6장 세계의 만성완전폐색(CTO) 시장 분석 : 최종 사용자별

• 개요 : 최종 사용자별
• 과거 및 예측 데이터 분석 : 최종 사용자별
• 병원
• 외래수술센터(ASC)
• 기타

제7장 세계의 만성완전폐색(CTO) 시장 분석 : 지역별

• 지역별 전망
• 서문
• 북미의 매출 분석
  • 개요, 분석 및 예측
  • 북미 : 부문별
  • 북미 국가별
  • 미국
  • 캐나다
  • 멕시코
• 유럽의 매출 분석
  • 개요, 분석 및 예측
  • 유럽 : 부문별
  • 유럽 국가별
  • 영국
  • 프랑스
  • 독일
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양의 매출 분석
  • 개요, 분석 및 예측
  • 아시아태평양 : 부문별
  • 아시아태평양 국가별
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주
  • 동남아시아
  • 기타 아시아태평양
• 라틴아메리카의 매출 분석
  • 개요, 분석 및 예측
  • 라틴아메리카 : 부문별
  • 라틴아메리카 국가별
  • 브라질
  • 아르헨티나
  • 페루
  • 칠레
  • 기타 라틴아메리카
• 중동 및 아프리카의 매출 분석
  • 개요, 분석 및 예측
  • 중동 및 아프리카 : 부문별
  • 중동 및 아프리카 국가별 일람
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 남아프리카
  • 기타 중동 및 아프리카

제8장 만성완전폐색(CTO) 기업 경쟁 구도

• 만성완전폐색(CTO) 시장의 경쟁
• 제휴, 협력 및 합의
• 합병 및 인수
• 신제품 발매
• 기타 개발

제9장 기업 프로파일

• 주요 기업의 시장 점유율 분석
• 시장 집중도
• Medtronic Plc
• Boston Scientific Corporation
• Abbott Laboratories
• Asahi Intecc Co. Ltd.
• Acrostak Int. Distr. SaRl
• Cook Medical
• Koninklijke Philips NV
• Terumo Corporation
• Teleflex Incorporated
• Becton
• Dickinson And Company
• Reflow Medical Inc.
• Cordis

AJY

영문 목차

영문목차

The global Chronic Total Occlusion market is forecasted to grow at a noteworthy CAGR of 6.49% between 2025 and 2033. By 2033, market size is expected to surge to USD 4.39 Billion, a substantial rise from the USD 2.49 Billion recorded in 2024.

The chronic total occlusion (CTO) market is poised for growth driven by advancements in interventional cardiology techniques and devices aimed at treating complex coronary artery blockages. Innovations in guidewires, microcatheters, and re-entry devices are improving procedural success rates and patient outcomes. Future developments will focus on imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enhance lesion visualization and guide interventions.

Moreover, increasing prevalence of cardiovascular diseases and aging populations are expanding patient pools. The integration of AI and robotics in CTO procedures is enhancing precision and reducing complications. Clinical research and guideline updates are supporting wider adoption of CTO interventions. As cardiovascular care advances, the CTO market will continue to innovate, delivering effective, minimally invasive treatment options.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Chronic Total Occlusion market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Microcatheters
• Guidewires
• Balloon Catheters
• Crossing Devices
• Stents
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others
• List of Companies Profiled in the report
• Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Asahi Intecc Co. Ltd., Acrostak Int. Distr. Sarl, Cook Medical, Koninklijke Philips N.V., Terumo Corporation, Teleflex Incorporated, Becton, Dickinson and Company, Reflow Medical Inc., Cordis.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CHRONIC TOTAL OCCLUSION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By End User
  • 3.7.3 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CHRONIC TOTAL OCCLUSION MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Microcatheters Historic and Forecast Sales By Regions
• 5.4. Guidewires Historic and Forecast Sales By Regions
• 5.5. Balloon Catheters Historic and Forecast Sales By Regions
• 5.6. Crossing Devices Historic and Forecast Sales By Regions
• 5.7. Stents Historic and Forecast Sales By Regions
• 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL CHRONIC TOTAL OCCLUSION MARKET ANALYSIS BY END USER

• 6.1. Overview By End User
• 6.2. Historical and Forecast Data Analysis By End User
• 6.3. Hospitals Historic and Forecast Sales By Regions
• 6.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL CHRONIC TOTAL OCCLUSION MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CHRONIC TOTAL OCCLUSION COMPANIES

• 8.1. Chronic Total Occlusion Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF CHRONIC TOTAL OCCLUSION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Medtronic Plc
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Boston Scientific Corporation
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Abbott Laboratories
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Asahi Intecc Co. Ltd.
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Acrostak Int. Distr. SaRl
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Cook Medical
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Koninklijke Philips N.V.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Terumo Corporation
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Teleflex Incorporated
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Becton
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Dickinson And Company
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. Reflow Medical Inc.
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. Cordis
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

관련자료